These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 16448850)

  • 1. International forum--the "6 Pillars" of best practice in apheresis technologies: introductory remarks.
    de Sousa G; Seghatchian J
    Transfus Apher Sci; 2006 Feb; 34(1):107-23. PubMed ID: 16448850
    [No Abstract]   [Full Text] [Related]  

  • 2. Transfusion and Apheresis Science. Editorial 38.2.
    Rock G
    Transfus Apher Sci; 2008 Apr; 38(2):89. PubMed ID: 18400559
    [No Abstract]   [Full Text] [Related]  

  • 3. [Blood component therapy today].
    Rebulla P; Bertolini F; Porretti L; Marangoni F; Smacchia C; Sirchia G
    Haematologica; 1991 Jun; 76 Suppl 3():405-10. PubMed ID: 1752540
    [No Abstract]   [Full Text] [Related]  

  • 4. World Apheresis Association.
    Rock G
    Transfus Apher Sci; 2010 Oct; 43(2):119. PubMed ID: 20888300
    [No Abstract]   [Full Text] [Related]  

  • 5. Current issues in transfusion medicine in Norway.
    Flesland O; Seghatchian J
    Transfus Apher Sci; 2005 Feb; 32(1):7-10. PubMed ID: 15737866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogen reduction technology: methods, status of clinical trials, and future prospects.
    Corash L
    Curr Hematol Rep; 2003 Nov; 2(6):495-502. PubMed ID: 14561394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Apheresis donation. Current views and perspectives].
    Schooneman F
    Transfus Clin Biol; 2005 Jun; 12(2):208-11. PubMed ID: 15925528
    [No Abstract]   [Full Text] [Related]  

  • 8. Bedside processing.
    Krause KP
    Vox Sang; 2004 Jul; 87 Suppl 2():76-8. PubMed ID: 15209884
    [No Abstract]   [Full Text] [Related]  

  • 9. International blood collection and storage: clinical use of blood products.
    Greening DW; Glenister KM; Sparrow RL; Simpson RJ
    J Proteomics; 2010 Jan; 73(3):386-95. PubMed ID: 19664733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quo vadis haemapheresis. Current developments in haemapheresis.
    Borberg H
    Transfus Apher Sci; 2006 Feb; 34(1):51-73. PubMed ID: 16412691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood banking and transfusion medicine for the nephrologist.
    Wehrli G
    Semin Dial; 2012; 25(2):114-8. PubMed ID: 22276991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogen reduction technologies: what are the concerns?
    AuBuchon JP
    Vox Sang; 2004 Jul; 87 Suppl 2():84-9. PubMed ID: 15209887
    [No Abstract]   [Full Text] [Related]  

  • 13. Pediatric transfusion: Global perspectives on some clinical and methodological aspects of cellular therapy, apheresis emergencies and blood transfusion in pediatric patients.
    Segatchian J; Sniecinski I
    Transfus Apher Sci; 2018 Jun; 57(3):306-307. PubMed ID: 29887185
    [No Abstract]   [Full Text] [Related]  

  • 14. [The status of blood component therapy in East Germany].
    Fünfhausen G
    Beitr Infusionsther; 1988; 21():354-6. PubMed ID: 2463009
    [No Abstract]   [Full Text] [Related]  

  • 15. Apheresis medicine in the era of advanced telehealth technologies: An American Society for Apheresis position paper part II: Principles of apheresis medical practice in a 21st century electronic medical practice environment.
    Linz W; Andrzejewski C; Hofmann JC
    J Clin Apher; 2022 Feb; 37(1):122-126. PubMed ID: 34837406
    [No Abstract]   [Full Text] [Related]  

  • 16. Apheresis technologies: an international perspective.
    Malchesky PS; Bambauer R; Horiuchi T; Kaplan A; Sakurada Y; Samuelsson G
    Artif Organs; 1995 Apr; 19(4):315-23. PubMed ID: 7598650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tailored collection of multicomponent by apheresis.
    Blanco L
    Transfus Apher Sci; 2002 Oct; 27(2):123-7. PubMed ID: 12350047
    [No Abstract]   [Full Text] [Related]  

  • 18. The Italian registry of therapeutic apheresis enters the information system of transfusion services - SISTRA.
    de Silvestro G; Catalano L; Marano G; Piccinini V; Pupella S; Ostuni A; de Angelis V
    Transfus Apher Sci; 2022 Feb; 61(1):103287. PubMed ID: 34627712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prospects of apheresis in the 21st century by new adsorption technologies.
    Klinkmann H
    Nephrol Dial Transplant; 2001; 16 Suppl 6():97-8. PubMed ID: 11568259
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma for fractionation: safety and quality issues.
    Farrugia A
    Haemophilia; 2004 Jul; 10(4):334-40. PubMed ID: 15230946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.